{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:14:09Z","timestamp":1778163249046,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.transproceed.2026.03.017","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:26:58Z","timestamp":1776144418000},"page":"808-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Haploidentical Transplantation Combined With Umbilical Cord Blood and Mesenchymal Stem Cells Co-Infusion for Aplastic Anemia: A Single-Center Retrospective Study"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6269-871X","authenticated-orcid":false,"given":"Zhengwei","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuechao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonglin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dijiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2026.03.017_bib0001","doi-asserted-by":"crossref","unstructured":"Scheinberg, P. Novel therapeutic choices in immune aplastic anemia. F1000Research 9, F1000 Faculty Rev (2020).","DOI":"10.12688\/f1000research.22214.1"},{"issue":"3","key":"10.1016\/j.transproceed.2026.03.017_bib0002","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.transproceed.2026.03.017_bib0003","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3324\/haematol.2014.106096","article-title":"Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"99","author":"Dufour","year":"2014","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.transproceed.2026.03.017_bib0004","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3324\/haematol.2014.109355","article-title":"First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy","volume":"99","author":"Yoshida","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.transproceed.2026.03.017_bib0005","doi-asserted-by":"crossref","first-page":"100772","DOI":"10.1016\/j.blre.2020.100772","article-title":"Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies","volume":"47","author":"Iftikhar","year":"2021","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.transproceed.2026.03.017_bib0006","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12185-024-03715-1","article-title":"Aplastic anemia: history and recent developments in diagnosis and treatment","volume":"119","author":"Onishi","year":"2024","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1016\/j.transproceed.2026.03.017_bib0007","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjh.17403","article-title":"Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries","volume":"194","author":"Scheinberg","year":"2021","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.transproceed.2026.03.017_bib0008","doi-asserted-by":"crossref","first-page":"17986","DOI":"10.3390\/ijms140917986","article-title":"Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy","volume":"14","author":"Jin","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.transproceed.2026.03.017_bib0009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/TP.0b013e31825940a4","article-title":"The comparison of interleukin 6-associated immunosuppressive effects of human ESCs, fetal-type MSCs, and adult-type MSCs","volume":"94","author":"Chan","year":"2012","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.transproceed.2026.03.017_bib0010","first-page":"1017","article-title":"Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials","volume":"91","author":"Lu","year":"2006","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.transproceed.2026.03.017_bib0011","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.transproceed.2026.03.017_bib0012","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbmt.2009.04.006","article-title":"A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD","volume":"15","author":"Guo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2026.03.017_bib0013","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.blre.2005.11.002","article-title":"The role of mesenchymal stem cells in haemopoiesis","volume":"20","author":"Dazzi","year":"2006","journal-title":"Blood Rev"},{"issue":"22","key":"10.1016\/j.transproceed.2026.03.017_bib0014","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMc1612872","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","year":"2016","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.transproceed.2026.03.017_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bjh.18530","article-title":"Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non-remission acute myeloid leukaemia: A nationwide retrospective study","volume":"201","author":"Matsuda","year":"2023","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.transproceed.2026.03.017_bib0016","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.transproceed.2026.03.017_bib0017","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3324\/haematol.13829","article-title":"Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study","volume":"94","author":"Scheinberg","year":"2009","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.transproceed.2026.03.017_bib0018","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/bmt.2014.84","article-title":"Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease","volume":"49","author":"Bhatia","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2026.03.017_bib0019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-019-0781-y","article-title":"Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients","volume":"12","author":"Wang","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.transproceed.2026.03.017_bib0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjh.14225","article-title":"Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study","volume":"175","author":"Xu","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.transproceed.2026.03.017_bib0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","article-title":"Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant","volume":"10","author":"Xu","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.transproceed.2026.03.017_bib0022","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/bmt.2014.187","article-title":"Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia","volume":"49","author":"Wang","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.transproceed.2026.03.017_bib0023","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/03007995.2018.1551193","article-title":"Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation","volume":"35","author":"Yu","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.transproceed.2026.03.017_bib0024","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s12015-023-10539-9","article-title":"Immunomodulatory mechanisms and therapeutic potential of mesenchymal stem cells","volume":"19","author":"Yang","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"issue":"1","key":"10.1016\/j.transproceed.2026.03.017_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12015-010-9165-y","article-title":"Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord","volume":"7","author":"Majore","year":"2011","journal-title":"Stem Cell Rev Rep"},{"issue":"8","key":"10.1016\/j.transproceed.2026.03.017_bib0026","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1182\/blood.V98.8.2396","article-title":"Identification of mesenchymal stem\/progenitor cells in human first-trimester fetal blood, liver, and bone marrow","volume":"98","author":"Campagnoli","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.transproceed.2026.03.017_bib0027","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/bmt.2017.35","article-title":"Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III\/IV after hematopoietic stem cell transplantation","volume":"52","author":"Dotoli","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"9419","key":"10.1016\/j.transproceed.2026.03.017_bib0028","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"9624","key":"10.1016\/j.transproceed.2026.03.017_bib0029","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet (lond. Engl.)"},{"issue":"5","key":"10.1016\/j.transproceed.2026.03.017_bib0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2020.01.018","article-title":"A phase 3, single-arm, prospective study of remestemcel-L, ex vivo culture-expanded adult human mesenchymal stromal cells for the treatment of pediatric patients who failed to respond to steroid treatment for acute graft-versus-host disease","volume":"26","author":"Kurtzberg","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.transproceed.2026.03.017_bib0031","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jamaoncol.2023.5757","article-title":"Mesenchymal stem cells for prophylaxis of chronic graft-vs-host disease after haploidentical hematopoietic stem cell transplant: an open-label randomized clinical trial","volume":"10","author":"Huang","year":"2024","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.transproceed.2026.03.017_bib0032","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.scr.2013.10.001","article-title":"Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells for severe aplastic anemia: successful engraftment and mild GVHD","volume":"12","author":"Wu","year":"2014","journal-title":"Stem Cell Res"},{"issue":"5","key":"10.1016\/j.transproceed.2026.03.017_bib0033","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/bmt.2016.347","article-title":"Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results","volume":"52","author":"Liu","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2026.03.017_bib0034","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720965411","article-title":"Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia","volume":"11","author":"Liu","year":"2020","journal-title":"Ther Adv Hematol"},{"issue":"12","key":"10.1016\/j.transproceed.2026.03.017_bib0035","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3324\/haematol.2016.149427","article-title":"Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups","volume":"101","author":"Inamoto","year":"2016","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.transproceed.2026.03.017_bib0036","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/bmt.2009.291","article-title":"Pediatric related and unrelated cord blood transplantation for malignant diseases","volume":"44","author":"Rocha","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"24","key":"10.1016\/j.transproceed.2026.03.017_bib0037","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1182\/blood-2011-08-372508","article-title":"Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.transproceed.2026.03.017_bib0038","doi-asserted-by":"crossref","first-page":"956.e1","DOI":"10.1016\/j.jtct.2025.08.028","article-title":"The optimal adjuvant reinfusion strategy for aplastic anemia: umbilical cord blood or mesenchymal stem cells? A single-center retrospective study","volume":"31","author":"Tan","year":"2025","journal-title":"Transplant Cell Therap"},{"key":"10.1016\/j.transproceed.2026.03.017_bib0039","doi-asserted-by":"crossref","first-page":"570179","DOI":"10.3389\/fcell.2021.570179","article-title":"Biological characteristics of umbilical cord mesenchymal stem cells and its therapeutic potential for hematological disorders","volume":"9","author":"Shang","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.transproceed.2026.03.017_bib0040","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1007\/s12013-024-01461-z","article-title":"In vitro chondrogenic induction promotes the expression level of IL-10 via the TGF-\u03b2\/SMAD and canonical wnt\/\u03b2-catenin signaling pathways in exosomes secreted by human adipose tissue-derived mesenchymal stem cells","volume":"82","author":"Semerci Sevimli","year":"2024","journal-title":"Cell Biochem Biophys"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526001703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526001703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:44:11Z","timestamp":1778161451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526001703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0041134526001703"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.03.017","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Haploidentical Transplantation Combined With Umbilical Cord Blood and Mesenchymal Stem Cells Co-Infusion for Aplastic Anemia: A Single-Center Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}